Evidence map›Paper›PMID 36744930›Full record

ArticleApplied and environmental microbiology2023

Yersinia pestis Δ

Anna M Kolodziejek, Scott W Bearden, Sarah Maes, John M Montenieri, Kenneth L Gage, Carolyn J Hovde, Scott A Minnich

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Applied and environmental microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 99% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Anna M KolodziejekDepartment of Animal, Veterinary and Food Science, University of Idaho, Moscow, Idaho, USA.
Scott W BeardenDivision of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado, USA.
Sarah MaesDivision of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado, USA.
John M MontenieriDivision of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado, USA.
Kenneth L GageDivision of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado, USA.
Carolyn J Hovde *Department of Animal, Veterinary and Food Science, University of Idaho, Moscow, Idaho, USA.
Scott A Minnich *Department of Animal, Veterinary and Food Science, University of Idaho, Moscow, Idaho, USA.ORCID 0000-0002-3202-9049
Centers for Disease Control and Prevention · USUniversity of Idaho · US

Funding

Variation in Human Innate ImmunityU54AI057141 · NIAID · UNIVERSITY OF WASHINGTON · PI GREENBERG, EVERETT P · 2003 to 2013
$102.3M
Women's health: interplay of maternal diet and key demographics on neurological health in the rural frontier and remote WestP20GM103408 · NIGMS · UNIVERSITY OF IDAHO · PI Carolyn Hovde Bohach · 2012 to 2026
$59.8M
NIAID NIH HHS U54 AI057141NIGMS NIH HHS P20 GM103408
6 · The paper itself

Abstract

Ail confers serum resistance in humans and is a critical virulence factor of Y. pestis, the causative agent of plague. Here, the contribution of Ail for Y. pestis survival in the flea vector was examined. Rat or human but not mouse sera were bactericidal against a Y. pestis Δ

Indexed as

PlagueSiphonapteraYersinia pestisAnimalsAnti-Bacterial AgentsBacterial Outer Membrane ProteinsComplement C3bHumansMammalsMiceRatsVirulence FactorsAil protein, Yersinia pestisAnti-Bacterial AgentsBacterial Outer Membrane ProteinsComplement C3bVirulence FactorsAilcomplementfleaLPSplagueserum resistancetransmissionYersinia pestis

Identifiers

PMID36744930
PMCPMC9973026
OpenAlexW4319295310

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.